Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has worked on ways to reduce their rate of misses when ...

CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.

GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm's prospects at an investor meeting last week would deflect criticism of her leadership from ...

GSK looks like it is starting to show the benefit of a revamp of its business under chief executive Emma Walmsley, with recent product launches driving a 10% rise in sales in the first quarter of ...

Following the divestment of the consumer group in 2022, GSK lowered the overall dividend to a level that is likely more appropriate for the earnings. Emma Walmsley succeeded Andrew Witty as CEO in ...

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases. During her eight years at ...